Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKCA | BMY | MRNA | AMGN | GILD |
| Company | Akcea Therapeutics Inc | Bristol-Myers Squibb Company | Moderna Inc | Amgen Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 18.15 | 49.00 | 111.05 | 270.63 | 66.58 |
| High | 18.17 | 49.05 | 111.29 | 274.86 | 67.19 |
| Low | 18.13 | 48.55 | 106.64 | 269.65 | 66.37 |
| Last | 18.17 | 48.92 | 108.82 | 273.58 | 66.86 |
| Change | +0.03 | -0.07 | +0.93 | +0.04 | -0.17 |
| % Change | +0.17% | -0.14% | +0.86% | +0.01% | -0.25% |
| Volume | 815,300 | 11,733,329 | 2,564,029 | 1,191,400 | 4,470,980 |
| 20-Day Average Volume | 661,490 | 11,027,962 | 3,182,211 | 2,105,998 | 6,280,066 |
| Previous Close | 18.14 | 48.99 | 107.89 | 273.54 | 67.03 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 18.14 | 50.37 | 105.19 | 271.60 | 69.06 |
| 20-Day Raw Stochastic | 70.59% | 18.15% | 59.87% | 47.59% | 12.61% |
| 20-Day Relative Strength | 73.10% | 41.15% | 55.92% | 49.11% | 32.46% |
| Weighted Alpha | -23.90 | -26.02 | -9.01 | +11.68 | -21.06 |
| Today's Opinion | 72% Buy | 88% Sell | 88% Buy | 40% Sell | 100% Sell |
| Previous Opinion | 64% Buy | 88% Sell | 88% Buy | 40% Sell | 100% Sell |
| Last Month's Opinion | 8% Buy | 8% Sell | 72% Buy | 24% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.22% since 10/02/20 | +2.13% since 04/17/24 | +4.71% since 04/17/24 | +3.74% since 04/17/24 | -0.04% since 04/17/24 |
| Low | 18.08 on 10/05/20 | 47.62 on 04/18/24 | 99.30 on 04/22/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 |
| High | 18.17 on 10/09/20 | 49.56 on 04/22/24 | 111.19 on 04/24/24 | 274.86 on 04/24/24 | 67.68 on 04/23/24 |
| 1-Month | |||||
| %Chg | +0.17% since 09/09/20 | -5.91% since 03/22/24 | +2.73% since 03/22/24 | -0.80% since 03/22/24 | -7.86% since 03/22/24 |
| Low | 18.05 on 09/21/20 | 47.62 on 04/18/24 | 97.00 on 04/03/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 |
| High | 18.22 on 09/28/20 | 54.47 on 03/28/24 | 115.89 on 04/09/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 |
| 3-Month | |||||
| %Chg | +36.72% since 07/09/20 | -2.75% since 01/24/24 | +7.12% since 01/24/24 | -10.33% since 01/24/24 | -15.87% since 01/24/24 |
| Low | 9.81 on 08/05/20 | 47.58 on 02/06/24 | 84.06 on 02/13/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 |
| High | 19.65 on 08/31/20 | 55.03 on 03/13/24 | 115.89 on 04/09/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 |
| 6-Month | |||||
| %Chg | +11.88% since 04/09/20 | -12.94% since 10/24/23 | +35.79% since 10/24/23 | -0.79% since 10/24/23 | -14.39% since 10/24/23 |
| Low | 9.81 on 08/05/20 | 47.58 on 02/06/24 | 62.55 on 11/02/23 | 249.70 on 10/31/23 | 65.90 on 04/18/24 |
| High | 19.65 on 08/31/20 | 56.77 on 10/25/23 | 115.97 on 01/08/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,846,054 | 99,290,928 | 41,308,924 | 146,720,288 | 83,457,512 |
| Shares Outstanding, K | 101,599 | 2,026,759 | 382,880 | 536,376 | 1,245,077 |
| Annual Sales | 488,540,000 | 45,006,000,000 | 6,848,000,000 | 28,190,000,000 | 27,116,000,000 |
| Annual Net Income | 40,770,000 | 8,025,000,000 | -4,714,000,000 | 6,717,000,000 | 5,665,000,000 |
| Last Quarter Sales | 22,380,000 | 11,477,000,000 | 2,811,000,000 | 8,196,000,000 | 7,114,000,000 |
| Last Quarter Net Income | -49,580,000 | 1,762,000,000 | 217,000,000 | 767,000,000 | 1,429,000,000 |
| 60-Month Beta | 1.45 | 0.39 | 1.62 | 0.58 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.49 on 08/04/20 | 1.70 on 02/02/24 | 0.55 on 02/22/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 |
| Latest Earnings Date | 11/03/20 | 04/25/24 | 05/02/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | 04/04/24 | N/A | 05/16/24 | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.55 | 0.00 | 14.58 | 9.96 |